Santo André, Brazil

Daniele Ribeiro De Araújo

This inventor holds 1 USPTO granted patent. Top assignees: Fundação Universidade Federal Do Abc - Ufabc, Technische Universitat Braunschweig. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniele Ribeiro De Araújo. Retrieved from https://idiyas.com/inventor/daniele-ribeiro-de-araújo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daniele Ribeiro De Araújo: Innovator in Biotechnology

Introduction

Daniele Ribeiro De Araújo is a notable inventor based in Santo André, Brazil. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. His work focuses on addressing medical challenges related to skin diseases.

Latest Patents

Daniele holds a patent for "Recombinant Human Antibodies That Inhibit the Human Tissue Kallikrein 7 (KLK7) and Their Use Against Diseases That Cause Desquamation of the Skin." This innovative patent highlights his commitment to advancing medical science and improving patient outcomes. He has 1 patent to his name.

Career Highlights

Throughout his career, Daniele has worked with esteemed institutions such as Fundação Universidade Federal do ABC (UFABC) and Technische Universität Braunschweig. His experiences in these organizations have enriched his expertise and contributed to his innovative research.

Collaborations

Daniele has collaborated with talented individuals in his field, including Luciano Puzer and Ana Flávia Santarine Laureano. These partnerships have fostered a collaborative environment that enhances the quality of research and innovation.

Conclusion

Daniele Ribeiro De Araújo is a distinguished inventor whose work in biotechnology is making a difference in the medical field. His innovative patents and collaborations reflect his dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…